The future of cell and gene therapy will be shaped not only by clinical breakthroughs but also by the industry's ability to connect patients, providers, payers and support services in an increasingly complex treatment environment.

This webinar explores the commercialization considerations that can help manufacturers strengthen launch readiness, coordinate patient support and scale access while preserving the specialized care advanced therapies require.

As more advanced therapies move toward commercialization, manufacturers face critical decisions that can influence launch readiness and long-term adoption. The featured speakers will discuss key considerations including distribution strategy, site readiness, patient identification, reimbursement challenges and ongoing patient support.

The speakers will discuss how organizations can build scalable, coordinated models that expand access while maintaining the specialized capabilities advanced therapies require and how commercialization planning is increasingly becoming a competitive advantage long before launch.

Register for this webinar to gain insight into how cell & gene therapy commercialization decisions can influence launch readiness, patient access and long-term adoption of advanced therapies.

3-part Cell & Gene Therapy Webinar Series:

Part 1:

Improve Cell & Gene Therapy Access Readiness as Pipelines Evolve

Part 2:

Expanding Cell & Gene Therapy Access Requires More Than Science

Part 3: (Register below) Scale Cell & Gene Therapy Access for Stronger Launch Readiness

Contact the host of Scale Cell & Gene Therapy Access for Stronger Launch Readiness (Broadcast 1)

There were 0 errors found in the information you submitted: